Literature DB >> 23417043

I(CaL) inhibition prevents arrhythmogenic Ca(2+) waves caused by abnormal Ca(2+) sensitivity of RyR or SR Ca(2+) accumulation.

Mathis K Stokke1, Nils Tovsrud, William E Louch, Leiv Øyehaug, Karina Hougen, Ole M Sejersted, Fredrik Swift, Ivar Sjaastad.   

Abstract

AIMS: Arrhythmogenic Ca(2+) waves result from uncontrolled Ca(2+) release from the sarcoplasmic reticulum (SR) that occurs with increased Ca(2+) sensitivity of the ryanodine receptor (RyR) or excessive Ca(2+) accumulation during β-adrenergic stimulation. We hypothesized that inhibition of the L-type Ca(2+) current (I(CaL)) could prevent such Ca(2+) waves in both situations. METHODS AND
RESULTS: Ca(2+) waves were induced in mouse left ventricular cardiomyocytes by isoproterenol combined with caffeine to increase RyR Ca(2+) sensitivity. I(CaL) inhibition by verapamil (0.5 µM) reduced Ca(2+) wave probability in cardiomyocytes during electrostimulation, and during a 10 s rest period after ceasing stimulation. A separate type of Ca(2+) release events occurred during the decay phase of the Ca(2+) transient and was not prevented by verapamil. Verapamil decreased Ca(2+) spark frequency, but not in permeabilized cells, indicating that this was not due to direct effects on RyR. The antiarrhythmic effect of verapamil was due to reduced SR Ca(2+) content following I(CaL) inhibition. Computational modelling supported that the level of I(CaL) inhibition obtained experimentally was sufficient to reduce the SR Ca(2+) content. Ca(2+) wave prevention through reduced SR Ca(2+) content was also effective in heterozygous ankyrin B knockout mice with excessive SR Ca(2+) accumulation during β-adrenergic stimulation.
CONCLUSION: I(CaL) inhibition prevents diastolic Ca(2+) waves caused by increased Ca(2+) sensitivity of RyR or excessive SR Ca(2+) accumulation during β-adrenergic stimulation. In contrast, unstimulated early Ca(2+) release during the decay of the Ca(2+) transient is not prevented, and merits further study to understand the full antiarrhythmic potential of I(CaL) inhibition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23417043     DOI: 10.1093/cvr/cvt037

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Synchronous systolic subcellular Ca2+-elevations underlie ventricular arrhythmia in drug-induced long QT type 2.

Authors:  Jong J Kim; Jan Němec; Qiao Li; Guy Salama
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-02-26

2.  Activation of CaMKIIδA promotes Ca2+ leak from the sarcoplasmic reticulum in cardiomyocytes of chronic heart failure rats.

Authors:  Le Gui; Xin Guo; Zhe Zhang; Hui Xu; Ya-Wei Ji; Ren-Jun Wang; Jiang-Hua Zhu; Qing-Hui Chen
Journal:  Acta Pharmacol Sin       Date:  2018-06-14       Impact factor: 6.150

3.  Elevated local [Ca2+] and CaMKII promote spontaneous Ca2+ release in ankyrin-B-deficient hearts.

Authors:  Iuliana Popescu; Samuel Galice; Peter J Mohler; Sanda Despa
Journal:  Cardiovasc Res       Date:  2016-04-30       Impact factor: 10.787

4.  Verapamil suppresses cardiac alternans and ventricular arrhythmias in acute myocardial ischemia via ryanodine receptor inhibition.

Authors:  Yu-Lei Deng; Jun-Yan Zhao; Ji-Hua Yao; Qiang Tang; Le Zhang; Hong-Lian Zhou; Cun-Tai Zhang; Jia-Gao Lv; Xiao-Qing Quan
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

Review 5.  Species-Dependent Mechanisms of Cardiac Arrhythmia: A Cellular Focus.

Authors:  Andrew G Edwards; William E Louch
Journal:  Clin Med Insights Cardiol       Date:  2017-02-02

6.  Simultaneous triple-parametric optical mapping of transmembrane potential, intracellular calcium and NADH for cardiac physiology assessment.

Authors:  Sharon A George; Zexu Lin; Igor R Efimov
Journal:  Commun Biol       Date:  2022-04-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.